Lv51
1262 积分 2021-01-04 加入
Identification of somatic genetic alterations in ovarian clear cell carcinoma with next generation sequencing
2小时前
已完结
Vascular Anomalies: Diagnosis of Complicated Anomalies and New Medical Treatment Options
6天前
已完结
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein–Overexpressing Advanced Non-Squamous EGFR-Wildtype NSCLC in the Phase 2 LUMINOSITY Trial
4个月前
已完结
Litifilimab (BIIB059), a promising investigational drug for cutaneous lupus erythematosus
6个月前
已完结
Hepatocellular Carcinoma
7个月前
已完结
MET alterations in advanced non-small cell lung cancer
1年前
已完结
MET alterations in NSCLC—Current Perspectives and Future Challenges
1年前
已完结
Tepotinib Treatment in Patients With MET Exon 14–Skipping Non–Small Cell Lung Cancer
1年前
已完结
Investigating the origins of recent pharmaceutical innovation
1年前
已完结
Dual role of EZH2 on megakaryocyte differentiation
1年前
已完结
皖公网安备34019202002308
